Lucile Blaise
First SEC filing: July 15, 2022 · Latest: July 15, 2022
Insider at
Insider transactions
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2023 | RMD | F | 135 | $143.60 | $19,386 | 10,305 Direct | -1.29% | Disposed | 76.1% (price as of ) |
| Aug. 25, 2023 | RMD | F | 380 | $165.67 | $62,955 | 10,355 Direct | -3.54% | Disposed | 52.6% (price as of ) |
| Aug. 17, 2023 | RMD | A | 819 | · | · | 7,441 Direct | +12.37% | Acquired | |
| Aug. 17, 2023 | RMD | A | 3,294 | · | · | 10,735 Direct | +44.27% | Acquired | |
| Nov. 21, 2022 | RMD | F | 114 | $224.40 | $25,582 | 6,705 Direct | -1.67% | Disposed | 12.7% (price as of ) |
| Nov. 21, 2022 | RMD | F | 78 | $224.40 | $17,503 | 6,627 Direct | -1.16% | Disposed | 12.7% (price as of ) |
| Nov. 21, 2022 | RMD | F | 75 | $224.40 | $16,830 | 6,552 Direct | -1.13% | Disposed | 12.7% (price as of ) |
| Nov. 16, 2022 | RMD | A | 2,410 | $224.58 | $541,238 | 2,410 Direct | · | Acquired | |
| Nov. 15, 2022 | RMD | F | 169 | $225.18 | $38,055 | 6,819 Direct | -2.42% | Disposed | 12.3% (price as of ) |
| Nov. 15, 2022 | RMD | M 10b5-1 | 516 | $225.18 | $116,193 | 7,504 Direct | +7.38% | Acquired | 12.3% (price as of ) |
| Nov. 15, 2022 | RMD | S 10b5-1 | 169 | $225.18 | $38,055 | 7,335 Direct | -2.25% | Disposed | 12.3% (price as of ) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 16, 2022 | RMD | ResMed Common Stock Options | ResMed Common Stock | $224.58 | Nov. 16, 2029 | 2,410 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 15, 2022 | RMD | ResMed Common Stock | 6,915 | Direct |
Holdings reported on Form 4 1 reported holding
Positions listed on each Form 4 without a transaction in that filing (Table I and II holdings), newest filing first.
| Date | Ticker | Security | Shares | Exercise price | Expiration | Ownership |
|---|---|---|---|---|---|---|
| Nov. 16, 2023 | RMD | ResMed Common Stock | 10,305 | · | · | Direct |